COVID-19 Worsens Chronic Lumbosacral Radicular Pain—Case Series Report
Abstract
1. Introduction
2. Materials and Methods
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- COVID-19 Dashboard. Available online: https://coronavirus.jhu.edu/map.html (accessed on 24 April 2022).
- Chen, X.; Zheng, F. Epidemiological and Clinical Features of 291 Cases with Coronavirus Disease 2019 in Areas Adjacent to Hubei, China: A Double-Center Observational Study. Available online: https://www.medrxiv.org/content/10.1101/2020.03.03.20030353v1 (accessed on 3 May 2021).
- Guan, W.J.; Ni, Z.Y. China Medical Treatment Expert Group for COVID-19. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 2020, 382, 1708–1720. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Raveendran, A.V.; Jayadevan, R.; Sashidharan, S. Long COVID: An overview. Diabetes Metab. Syndr. 2021, 15, 869–875. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Lopez-Leon, S.; Wegman-Ostrosky, T.; Perelman, C. More than 50 Long-term effects of COVID-19: A systematic review and meta-analysis. Sci. Rep. 2021, 11, 16144. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- WHO China Joint Mission on COVID-19 Final Report. Available online: https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf (accessed on 25 February 2021).
- Paliwal, V.K.; Garg, R.K.; Gupta, A.; Tejan, N. Neuromuscular presentations in patients with COVID-19. Neurol. Sci. 2020, 41, 3039–3056. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Bartoš, H.; Fabianová, L.; Dlouhý, P.D. Ospalík.: COVID-19 asociovaná myelitida—Kazuistika vzácné komplikace závažné SARS-CoV-2 infekce (COVID-19 associated myelitis—A case report of rare complication of severe SARS-CoV-2 infection). Ces. Slov. Neurol. Neurochir. 2021, 84/117, 410–412. [Google Scholar]
- Munz, M.; Wessendorf, S.; Koretsis, G.; Tewald, F.; Baegi, R.; Krämer, S.; Geissler, M.; Reinhard, M. Acute transverse myelitis after COVID-19 pneumonia. J. Neurol. 2020, 267, 2196–2197. [Google Scholar] [CrossRef] [Scilit]
- AlKetbi, R.; AlNuaimi, D.; AlMulla, M.; AlTalai, N.; Samir, M.; Kumar, N.; AlBastaki, U. Acute myelitis as a neurological complication of Covid-19: A case report and MRI findings. Radiol. Case Rep. 2020, 15, 1591–1595. [Google Scholar] [CrossRef] [Scilit]
- Zhao, K.; Huang, J.; Dai, D.; Feng, Y.; Liu, L.; Nie, S. Acute myelitis after SARS-CoV-2 infection: A case report (PREPRINT). MedRxiv 2020. [Google Scholar] [CrossRef] [Scilit]
- Guo, F.; Zhang, Y.B. Clinical features and prognosis of patients with Guillain-Barré and acute transverse myelitis overlap syndrome. Clin. Neurol. Neurosurg. 2019, 181, 127–132. [Google Scholar] [CrossRef] [Scilit]
- Chochol, J.; Džubera, A.; Illéš, R.; Chocholová, A.; Zemková, E. Vertebral Pain in Acute COVID-19—Cases Report. Appl. Sci. 2021, 11, 6926. [Google Scholar] [CrossRef] [Scilit]
- Džubera, A.; Chochol, J.; Illéš, R.; Chocholová, A.; Zemková, E. Vertebral Algic Syndrome Treatment in Long COVID-Cases Reports. Int. J. Environ. Res. Public Health 2021, 21, 11457. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Niazkar, H.R.; Zibaee, B.; Nasimi, A. The neurological manifestations of COVID-19: A review article. Neurol. Sci. 2020, 41, 1667–1671. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Yachou, Y.; El Idrissi, A.; Belapasov, V.; Ait Benali, S. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: Understanding the neurological manifestations in COVID-19 patients. Neurol. Sci. 2020, 41, 2657–2669. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Mao, L.; Jin, H.; Wang, M.; Hu, Y.; Chen, S.; He, Q.; Chang, J.; Hong, C.; Zhou, Y.; Wang, D.; et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020, 77, 683–690. [Google Scholar] [CrossRef] [Scilit]
- Murat, S.; Karatekin, B.D. Clinical presentations of pain in patients with COVID-19 infection. Ir. J. Med. Sci. 2021, 190, 913–917. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Giacomelli, A.; Pezzati, L. Self-reported Olfactory and Taste Disorders in Patients with Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study. Clin. Infect. Dis. 2020, 71, 889–890. [Google Scholar] [CrossRef] [Scilit]
- Kirschenmbaum, D.; Imbach, L.L.; Ulrich, S.; Rushing, E.J.; Keller, E.; Reimann, R.R.; Frauenknecht, K.B.; Lichtblau, M.; Witt, M.; Hummel, T.; et al. Inflammatory olfactory neuropathy in two patients with Covid-19. Lancet 2020, 396, 166. [Google Scholar] [CrossRef] [Scilit]
- Paybast, S.; Gorji, R.; Mavandadi, S. Guillain-Barré syndrome as a neurological complication of novel COVID-19 infection: A case report and review of the literature. Neurologist 2020, 25, 101–103. [Google Scholar] [CrossRef] [Scilit]
- Moreira, M.S.; Neves, I.L.I.; de Bernoche, C.Y.S.M.; Sarra, G.; dos Santos-Paul, M.A.; da Silva, F.C.N.; Schroter, G.T.; Montano, T.C.P.; de Carvalho, C.M.A.; Neves, R.S. Bilateral paresthesia associated with cardiovascular disease and COVID-19. Oral Dis. 2022, 28 (Suppl. S1), 912–915. [Google Scholar] [CrossRef] [Scilit]
- Merskey, H.; Bogduk, N. Classification of Chronic Pain, 2nd ed. (e-Book). 2012, p. 7. Available online: www.iasp-pain.org/publications/free-ebooks/classification-of-chronic-pain-second-edition-revised/ (accessed on 4 April 2022).
- Karcioglu, O.; Topacoglu, H.; Dikme, O.; Dikme, O. A systematic review of the pain scales in adults: Which to use? Am. J. Emerg. Med. 2018, 36, 707–714. [Google Scholar] [CrossRef] [Scilit]
- Crichton, N. Visual analogue scale (VAS). J. Clin. Nurs. 2001, 10, 706. [Google Scholar]
- Klimek, L.; Bergmann, K.C.; Biedermann, T.; Bousquet, J.; Hellings, P.; Jung, K.; Merk, H.; Olze, H.; Schlenter, W.; Stock, P.; et al. Visual analogue scales (VAS): Measuring instruments for the documentation of symptoms and therapy monitoring in cases of allergic rhinitis in everyday health care. Allergo J. Int. 2017, 26, 16–24. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Desforges, M.; Le Coupanec, A.; Stodola, J.K.; Meessen-Pinard, M.; Talbot, P.J. Human coronaviruses: Viral and cellular factors involved in neuroinvasiveness and neuropathogenesis. Virus Res. 2014, 194, 145–158. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Netland, J.; Meyerholz, D.K.; Moore, S.; Cassell, M.; Perlman, S. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J. Virol. 2008, 82, 7264–7275. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Yeh, E.A.; Collins, A.; Cohen, M.E.; Duffner, P.K.; Faden, H. Detection of coronavirus in the central nervous system of a child with acute disseminated encephalomyelitis. Pediatrics 2004, 113, e73–e76. [Google Scholar]
- Natoli, S.; Oliveira, V.; Calabresi, P.; Maia, L.F.; Pisani, A. Does SARS-Cov-2 invade the brain? Translational lessons from animal models. Eur. J. Neurol. 2020, 27, 1764–1773. [Google Scholar] [CrossRef] [Scilit]
- Gu, J.; Gong, E.; Zhang, B.; Zheng, J.; Gao, Z.; Zhong, Y.; Zou, W.; Zhan, J.; Wang, S.; Xie, Z.; et al. Multiple organ infection and the pathogenesis of SARS. J. Exp. Med. 2005, 202, 415–424. [Google Scholar] [CrossRef] [Scilit]
- Spiegel, M. Interaction of severe acute respiratory syndrome-associated coronavirus with dendritic cells. J. Gen. Virol. 2006, 87, 1953–1960. [Google Scholar] [CrossRef] [Scilit]
- Hao, X.; Lv, Q.; Li, F.; Xu, Y.; Gao, H. The characteristics of hDPP4 transgenic mice subjected to aerosol MERS coronavirus infection via an animal nose-only exposure device. Anim. Models Exp. Med. 2019, 2, 269–281. [Google Scholar] [CrossRef] [Scilit]
- Conde Cardona, G.; Quintana Pájaro, L.D.; Quintero Marzola, I.D.; Ramos Villegas, Y.; Moscote Salazar, L.R. Neurotropism of SARS-CoV 2: Mechanisms and manifestations. J. Neurol. Sci. 2020, 412, 116824. [Google Scholar] [CrossRef] [Scilit]
- Brann, D.H.; Tsukahara, T.; Weinreb, C.; Logan, D.W.; Datta, S.R. Non-neural expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci. Adv. 2020, 6, eabc5801. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Bayati, A.; Kumar, R.; Francis, V.; McPherson, P.S. SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis. J. Biol. Chem. 2021, 296, 100306. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Zhou, J.; Chu, H.; Li, C.; Wong, B.H.Y.; Cheng, Z.S.; Poon, V.K.M.; Sun, T.; Lau, C.C.Y.; Wong, K.K.Y.; Chan, J.Y.W.; et al. Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: Implications for pathogenesis. J. Infect. Dis. 2014, 209, 1331–1342. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Li, Y.C.; Bai, W.Z.; Hirano, N.; Hayashida, T.; Hashikawa, T. Coronavirus infection of rat dorsal root ganglia: Ultrastructural characterization of viral replication, transfer, and the early response of satellite cells. Virus Res. 2012, 163, 628–635. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Li, Y.; Fu, L.; Gonzales, D.M.; Lavi, E. Coronavirus neurovirulence correlates with the ability of the virus to induce proinflammatory cytokine signals from astrocytes and microglia. J. Virol. 2004, 78, 3398–3406. [Google Scholar] [CrossRef] [Scilit]
- Arbour, N.; Day, R.; Newcombe, J.; Talbot, P.J. Neuroinvasion by human respiratory coronaviruses. J. Virol. 2000, 74, 8913–8921. [Google Scholar] [CrossRef] [Scilit]
- COVID-19 Treatment Guidelines. Available online: https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/ (accessed on 15 December 2021).
- Greenhalgh, T.; Knight, M.; Court, C. Management of post-acute covid-19 in primary care. BMJ 2020, 370, 3026. [Google Scholar] [CrossRef] [Scilit]
- Cohen, J. Statistical Power Analysis for the Behavioral Science; Lawrence Erlbaum Associates: Hillsdale, NJ, USA, 1988; pp. 19–66. [Google Scholar]
- Faul, F.; Erdfelder, E. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav. Res. Methods 2007, 39, 175–191. [Google Scholar] [CrossRef] [Scilit]
- Booth, F.W.; Lees, S.J. Physically active subjects should be the control group. Med. Sci. Sports Exerc. 2006, 38, 405–406. [Google Scholar] [CrossRef] [Scilit]
- Zubair, A.S.; McAlpine, L.S.; Gardin, T.; Farhadian, S.; Kuruvilla, D.E.; Spudich, S. Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review. JAMA Neurol. 2020, 77, 1018–1027. [Google Scholar] [CrossRef] [Scilit]
- Gialluisi, A.; de Gaetano, G.; Iacoviello, L. New challenges from Covid-19 pandemic: An unexpected opportunity to enlighten the link between viral infections and brain disorders? Neurol. Sci. 2020, 41, 1349–1350. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Sarkesh, A.; Daei Sorkhabi, A. Extrapulmonary Clinical Manifestations in COVID-19 Patients. Am. J. Trop. Med. Hyg. 2020, 103, 1783–1796. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Cipollaro, L.; Giordano, L. Musculoskeletal symptoms in SARS-CoV-2 (COVID-19) patients. J. Orthop. Surg. Res. 2020, 15, 178–185. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern. Available online: https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern (accessed on 14 January 2022).
- SARS-CoV-2 Variant Classifications and Definitions. Available online: https://www.cdc.gov/coronavirus/2019-ncov/variants/variant-classifications.html (accessed on 14 January 2022).
- Chen, J.; Wang, R.; Gilby, N.B.; Wei, G.W. Omicron Variant (B.1.1.529): Infectivity, Vaccine Breakthrough, and Antibody Resistance. J. Chem. Inf. Model. 2022, 62, 412–422. [Google Scholar] [CrossRef] [Scilit]
| Patient | Sex | Age (Years) | Pre-COVID-19 VAS | Peri-COVID-19 VAS | Post-COVID-19 VAS |
|---|---|---|---|---|---|
| 1 | M | 41 | 7 | 10 | 7 |
| 2 | F | 47 | 6 | 9 | 7 |
| 3 | M | 51 | 4 | 8 | 5 |
| 4 | M | 50 | 7 | 9 | 7 |
| 5 | F | 53 | 6 | 7 | 6 |
| 6 | M | 54 | 4 | 6 | 4 |
| 7 | F | 55 | 6 | 9 | 6 |
| 8 | M | 55 | 5 | 7 | 5 |
| 9 | M | 57 | 5 | 7 | 5 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Illéš, R.; Chochol, J.; Džubera, A.; Chocholová, A.; Zemková, E. COVID-19 Worsens Chronic Lumbosacral Radicular Pain—Case Series Report. Int. J. Environ. Res. Public Health 2022, 19, 6410. https://doi.org/10.3390/ijerph19116410
Illéš R, Chochol J, Džubera A, Chocholová A, Zemková E. COVID-19 Worsens Chronic Lumbosacral Radicular Pain—Case Series Report. International Journal of Environmental Research and Public Health. 2022; 19(11):6410. https://doi.org/10.3390/ijerph19116410
Chicago/Turabian StyleIlléš, Róbert, Juraj Chochol, Andrej Džubera, Alica Chocholová, and Erika Zemková. 2022. "COVID-19 Worsens Chronic Lumbosacral Radicular Pain—Case Series Report" International Journal of Environmental Research and Public Health 19, no. 11: 6410. https://doi.org/10.3390/ijerph19116410
APA StyleIlléš, R., Chochol, J., Džubera, A., Chocholová, A., & Zemková, E. (2022). COVID-19 Worsens Chronic Lumbosacral Radicular Pain—Case Series Report. International Journal of Environmental Research and Public Health, 19(11), 6410. https://doi.org/10.3390/ijerph19116410

